← FDA DRUG APPROVALS

FDA ANDA · ANDA201512

PIRMELLA 1/35

Sponsor: LUPIN LTD

APPLICATION
ANDA201512
TYPE
ANDA
ORIGINAL APPROVAL
2013-04-24
LATEST ACTION
2022-04-29
ROUTE
ORAL-28
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

PIRMELLA 1/35Discontinued
ETHINYL ESTRADIOL 0.035MG, NORETHINDRONE 1MG · TABLET · ORAL-28

Approval history

2022-04-29Labeling · Supplement 13 · standardAP
2019-04-29Manufacturing (CMC) · Supplement 11 · unknownAP
2019-03-22Labeling · Supplement 8 · standardAP
2016-08-22Labeling · Supplement 5 · standardAP
2015-04-13Labeling · Supplement 4 · standardAP
2013-04-24Not Applicable · OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →